Biomarkers in Pediatric Heart Failure

June 28, 2018 (Noon - 1:30 p.m. ET)


Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB), Best Pharmaceuticals for Children Act (BPCA), NICHD


Cardiomyopathy during infancy and childhood can lead to death in infants and children. It also contributes to cardiomyopathies in adults. Cardiomyopathy is the leading cause of heart transplant for children and teenagers and results in considerable health care costs.

Steven E. Lipshultz, M.D., FAAP, FAHA, will discuss causes, risk factors and biomarkers for infants and children with cardiomyopathy and heart failure, as well as preventive strategies that may improve outcomes.


George Giacoia, OPPTB, NICHD
Phone: (301) 496-5589

Please note: Views expressed during NICHD-sponsored events do not necessarily reflect the opinions or the official positions of NICHD, NIH, or HHS.
top of pageBACK TO TOP